HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED Hansoh Pharmaceutical Group Company Limited Share Price Börse Stuttgart
Equities
3KY
KYG549581067
Pharmaceuticals
|
Market Closed -
Other stock markets
|
After market 01:21:55 am | |||
| 1.93 EUR | -2.03% |
|
1.955 | +1.30% |
| 29/04 | Hansoh Pharmaceutical Group Company Limited Announces Executive Changes, Effective April 29, 2024 | CI |
| 03/04 | Hansoh Pharmaceutical Secures Chinese Nod for Trial of Anti-Cancer Drug | MT |
| Sales 2024 * | 1.18TCr 163.18Cr 150.29Cr 14TCr | Sales 2025 * | 1.25TCr 172.4Cr 158.78Cr 14TCr | Capitalization | 9.13TCr 1.26TCr 1.16TCr 1,04800Cr |
|---|---|---|---|---|---|
| Net income 2024 * | 374.2Cr 52Cr 48Cr 4.29TCr | Net income 2025 * | 380.9Cr 53Cr 48Cr 4.37TCr | EV / Sales 2024 * | 5.93 x |
| Net cash position 2024 * | 2.12TCr 293.12Cr 269.96Cr 24TCr | Net cash position 2025 * | 2.39TCr 329.37Cr 303.35Cr 27TCr | EV / Sales 2025 * | 5.4 x |
| P/E ratio 2024 * |
24
x | P/E ratio 2025 * |
23.8
x | Employees | - |
| Yield 2024 * |
1% | Yield 2025 * |
1.03% | Free-Float | 18.24% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 week | -5.29% | ||
| Current month | -4.37% | ||
| 1 month | -2.48% | ||
| 3 months | +27.92% | ||
| 6 months | +16.57% | ||
| Current year | +15.20% |
1 week
1.91
2.06
1 month
1.912.16
3 years
1.113.70
| Managers | Title | Age | Since |
|---|---|---|---|
Hui Juan Zhong
CEO | Chief Executive Officer | 63 | 02/15/02 |
Sheng Li Zhong
SEC | Corporate Secretary | 56 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Guo Qiang Lin
BRD | Director/Board Member | 81 | 31/19/31 |
Sheung Wai Chan
BRD | Director/Board Member | 70 | 14/19/14 |
Dong Tao Yang
BRD | Director/Board Member | 67 | - |
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 1.93 | -2.03% |
| 27/24/27 | 1.97 | +1.55% |
| 24/24/24 | 1.94 | -3.96% |
| 23/24/23 | 2.02 | +1.51% |
| 22/24/22 | 1.99 | -3.40% |
Delayed Quote Börse Stuttgart, May 28, 2024 at 02:26 pm IST
More quotes
Hansoh Pharmaceutical Group Company Limited specializes in the development, manufacture and marketing of pharmaceutical products for the treatment of tumor, infectious, metabolic and autoimmune diseases. Net sales break down by revenue source as follows:
- sales of pharmaceutical products (99.1%);
- sales of research and development services (0.9%).
Sector
Pharmaceuticals
Calendar
29/08/2024
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
15.42
CNY
Average target price
17.81
CNY
Spread / Average Target
+15.55%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +38.59% | 73TCr | |
| -7.89% | 35TCr | |
| +15.66% | 33TCr | |
| +0.24% | 28TCr | |
| +13.47% | 24TCr | |
| +7.35% | 21TCr | |
| -6.42% | 20TCr | |
| +4.23% | 16TCr | |
| -1.70% | 16TCr |
- Stock Market
- Equities
- 3692 Stock
- 3KY Stock
